PubMed

Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome.

Khan BV, Sola S, Lauten WB, Natarajan R, Hooper WC, Menon RG, Lerakis S, Helmy T.

Diabetes Care. 2004 Jul;27(7):1712-5.PMID: 15220251 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome.

Nagamia S, Pandian A, Cheema F, Natarajan R, Khan QA, Patel AD, Merchant N, Sola S, Khan BV.

Prev Cardiol. 2007 Fall;10(4):204-9.PMID: 17917517 [PubMed - indexed for MEDLINE]Related articles

Effects of angiotensin-converting enzyme inhibitor therapy on levels of inflammatory markers in response to exercise-induced stress: studies in the metabolic syndrome.

Vaccari CS, Rahman ST, Khan QA, Cheema FA, Khan BV.

J Cardiometab Syndr. 2008 Winter;3(1):12-7.PMID: 18326980 [PubMed - indexed for MEDLINE]Related articles

Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.

Voors AA, van Geel PP, Oosterga M, Buikema H, van Veldhuisen DJ, van Gilst WH.

J Renin Angiotensin Aldosterone Syst. 2004 Sep;5(3):130-4.PMID: 15526248 [PubMed - indexed for MEDLINE]Related articles

Mechanism by which quinapril improves vascular function in coronary artery disease.

Koh KK, Bui MN, Hathaway L, Csako G, Waclawiw MA, Panza JA, Cannon RO 3rd.

Am J Cardiol. 1999 Feb 1;83(3):327-31.PMID: 10072217 [PubMed - indexed for MEDLINE]Related articles

[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)]

Skvortsov AA, Nasonova SN, Sychev AV, Arbolishvili GN, Baklanova NA, Mareev VIu, Belenkov IuN.

Ter Arkh. 2005;77(8):34-43. Russian. PMID: 16206603 [PubMed - indexed for MEDLINE]Related articles

Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.

Pepine CJ, Rouleau JL, Annis K, Ducharme A, Ma P, Lenis J, Davies R, Thadani U, Chaitman B, Haber HE, Freedman SB, Pressler ML, Pitt B; QUASAR Study Group.

J Am Coll Cardiol. 2003 Dec 17;42(12):2049-59.PMID: 14680725 [PubMed - indexed for MEDLINE]Related articles

Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure.

White M, Lepage S, Lavoie J, De Denus S, Leblanc MH, Gossard D, Whittom L, Racine N, Ducharme A, Dabouz F, Rouleau JL, Touyz R.

J Card Fail. 2007 Mar;13(2):86-94.PMID: 17395047 [PubMed - indexed for MEDLINE]Related articles

The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis.

Dalbeth N, Edwards J, Fairchild S, Callan M, Hall FC.

Rheumatology (Oxford). 2005 Jan;44(1):24-31. Epub 2004 Sep 7.PMID: 15353612 [PubMed - indexed for MEDLINE]Related articlesFree article

Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome.

Yiginer O, Ozcelik F, Inanc T, Aparci M, Ozmen N, Cingozbay BY, Kardesoglu E, Suleymanoglu S, Sener G, Cebeci BS.

Clin Res Cardiol. 2008 May;97(5):334-40. Epub 2007 Dec 28.PMID: 18330493 [PubMed - indexed for MEDLINE]Related articles

Quinapril treatment enhances vascular sensitivity to insulin.

Feldman RD, Schmidt ND.

J Hypertens. 2001 Jan;19(1):113-8.PMID: 11204290 [PubMed - indexed for MEDLINE]Related articles

Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.

Schindler C, Mueller A, Bramlage P, Boecking W, Kirch W, Schweizer J.

Angiology. 2007 Dec-2008 Jan;58(6):710-6. Epub 2007 Oct 10.PMID: 17928625 [PubMed - indexed for MEDLINE]Related articles

Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators.

Oosterga M, Voors AA, Buikema H, Pinto YM, Haber HE, Ebels T, Morshuis WJ, Kingma JH, Crijns HJ, van Gilst WH.

Cardiovasc Drugs Ther. 2000 Feb;14(1):55-60.PMID: 10755201 [PubMed - indexed for MEDLINE]Related articles

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.

Gliddon AE, Doré CJ, Black CM, McHugh N, Moots R, Denton CP, Herrick A, Barnes T, Camilleri J, Chakravarty K, Emery P, Griffiths B, Hopkinson ND, Hickling P, Lanyon P, Laversuch C, Lawson T, Mallya R, Nisar M, Rhys-Dillon C, Sheeran T, Maddison PJ.

Arthritis Rheum. 2007 Nov;56(11):3837-46.PMID: 17968938 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of quinapril on the attenuated heart rate recovery of type 2 diabetic subjects without known coronary artery disease.

Sipahi I, Tekin G, Yigit Z, Guzelsoy D, Guven O.

Clin Cardiol. 2004 Aug;27(8):480-4.PMID: 15346847 [PubMed - indexed for MEDLINE]Related articles

Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study.

Sola S, Mir MQ, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, Khan BV.

Circulation. 2005 Jan 25;111(3):343-8. Epub 2005 Jan 17.PMID: 15655130 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.

Napoli C, Bruzzese G, Ignarro LJ, Crimi E, de Nigris F, Williams-Ignarro S, Libardi S, Sommese L, Fiorito C, Mancini FP, Cacciatore F, Liguori A.

Am Heart J. 2008 Dec;156(6):1154.e1-8.PMID: 19033012 [PubMed - indexed for MEDLINE]Related articles

Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition.

Kobayashi N, Honda T, Yoshida K, Nakano S, Ohno T, Tsubokou Y, Matsuoka H.

Atherosclerosis. 2006 Jul;187(1):92-100. Epub 2005 Oct 7.PMID: 16214149 [PubMed - indexed for MEDLINE]Related articles

The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention.

Texter M, Lees RS, Pitt B, Dinsmore RE, Uprichard AC.

Cardiovasc Drugs Ther. 1993 Apr;7(2):273-82.PMID: 8357782 [PubMed - indexed for MEDLINE]Related articles

Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy.

Didangelos TP, Arsos GA, Karamitsos DT, Athyros VG, Georga SD, Karatzas ND.

J Diabetes Complications. 2006 Jan-Feb;20(1):1-7.PMID: 16389160 [PubMed - indexed for MEDLINE]Related articles